Real-time enrollment status for this estrogen-receptor-positive breast cancer clinical trial
Current Status
Recruiting
Checked: October 15, 2026 at 7:55 PM UTC
| NCT Number | NCT07222215 |
| Recruiting Status | Recruiting |
| Condition | Estrogen-receptor-positive Breast Cancer |
| Phase | PHASE2 |
| Target Enrollment | 297 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Kristina A. Fanucci |
| Last Updated on CT.gov | August 26, 2026 (Aug 26, 2026) |
As of October 15, 2026: Clinical trial NCT07222215 is currently recruiting participants. This phase2 study for estrogen-receptor-positive breast cancer is actively seeking new participants at 1 location across the United States. The study is sponsored by Kristina A. Fanucci. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07222215 is actively recruiting participants as of October 15, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07222215 was last updated Aug 26, 2026 (August 26, 2026). HelloStudys verifies this status automatically.